Ceftriaxone sodium and Obstruction - a phase IV clinical study of FDA data

Summary:

Obstruction is reported as a side effect among people who take Ceftriaxone sodium (ceftriaxone sodium), especially for people who are female, 60+ old, also take Asacol, and have Crohn's disease.

The phase IV clinical study analyzes which people have Obstruction when taking Ceftriaxone sodium. It is created by eHealthMe based on reports of 6,546 people who have side effects when taking Ceftriaxone sodium from the FDA, and is updated regularly.

What is Ceftriaxone sodium?

Ceftriaxone sodium has active ingredients of ceftriaxone sodium. eHealthMe is studying from 6,549 Ceftriaxone sodium users. Check the latest studies of Ceftriaxone sodium.

What is Obstruction?

Obstruction is found to be associated with 469 drugs and 647 conditions by eHealthMe. Check the latest studies of Obstruction.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 21, 2026

6,546 people reported to have side effects when taking Ceftriaxone sodium.
Among them, 19 people (0.29%) have Obstruction.

Could Ceftriaxone sodium cause Obstruction?

Among these 19 people:

What is the gender of people who have Obstruction when taking Ceftriaxone sodium? *

female: 100 %
male: 0.0 %

What is the age of people who have Obstruction when taking Ceftriaxone sodium? *

What are other drugs people take besides Ceftriaxone sodium? *

What are other side effects people have besides Obstruction? *

Traumatic Injury Of The Bladder And Urethra: 19 people, 100.00%
Suicide Attempt: 19 people, 100.00%
Pain: 19 people, 100.00%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 19 people, 100.00%
Malaise (a feeling of general discomfort or uneasiness): 19 people, 100.00%
Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 19 people, 100.00%
Joint Pain: 11 people, 57.89%
Feeling Abnormal: 11 people, 57.89%
Depression Suicidal (suicide depressive disorder): 11 people, 57.89%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 19 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftriaxone sodium and have Obstruction?

- Check whether Obstruction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ceftriaxone sodium:

Ceftriaxone sodium (6,549 reports)

Obstruction treatments and more:

Obstruction (4,654 reports)

Browse all side effects of Ceftriaxone sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Obstruction:

Obstruction (469 drugs)

Browse all the conditions that are associated with Obstruction:

Obstruction (647 conditions)

Related publications that referenced our studies

Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on ceftriaxone sodium (the active ingredients of Ceftriaxone sodium) and Ceftriaxone sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.